Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > It has been 4 years of burning money and paying a CEO 4 zip
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Jun 20, 2022 12:00am
185 Views
Post# 34768015

RE:It has been 4 years of burning money and paying a CEO 4 zip

RE:It has been 4 years of burning money and paying a CEO 4 zip Typical pumper , only name calling and insults , no Tetra information , no Tetra facts , no wanting to hold money hiding Tetra CEO accountable after feeding his privately held numbered company for years to the tune of  over 720,000 US on shareholders money.Company goes from 1.50 to .055 cents and you pumpers are ok with paying and keeping a CEO  that promised shareholders product and revenue years ago.
Syqe was miles ahead of Tetra and Guys make work  Qixleef dream, Qixleef will never be used in a medical setting / building where there is oxygen .  Doesn't matter they don't have the funding 500,000,000 or the 10 years before it is worth any more than a good wage for Guy .Tetra is on life support and will be unless the CEO is held accountable for his money wastage and bad deals with Panag  and the other deals he made, go READ HIS STATEMENTS Guy said revenue after he connected with Panag , Breakout year 2020 here we come.When you give money to a CEO with no results after years of promises , its a scam .
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities